(Q80216002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Gremlin promotes vascular smooth muscle cell proliferation and migration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Thiago Trovati Maciel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Rosilene S Melo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Nestor Schor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alexandre H Campos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

12 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

370-379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

The intima. Soil for atherosclerosis and restenosis.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Molecular mechanisms in intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

The multiple actions of angiotensin II in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Angiotensin AT1/AT2 receptors: regulation, signalling and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

PDGF and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenetic proteins and their antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

BMP signaling and skeletogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenetic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenetic protein signaling in stem cells--one signal, many consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenetic proteins in vascular calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Controlling cell fate by bone morphogenetic protein receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Angiotensin-receptor blockers: revival of the systemic prevention of restenosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.10.021

10.1016/J.YJMCC.2007.10.021

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18086474%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference